VWM
ROIV icon

Vermillion Wealth Management’s Roivant Sciences ROIV Stock Holding History

Vermillion Wealth Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-59
Closed -$1.63K – 2263
2026
Q1 		$1.63K Buy
+59
New +$1.52K ﹤0.01% 698

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vermillion Wealth Management's ROIV Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 59 shares — an estimated $1.63K sold.

Vermillion Wealth Management first reported a position in ROIV in Q1 2026 and held it in 1 quarter. The position peaked at $1.63K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Vermillion Wealth Management reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • Vermillion Wealth Management sold 59 Roivant Sciences shares in Q2 2026, an estimated $1.63K.
  • Vermillion Wealth Management first reported a position in Roivant Sciences in Q1 2026 and held it in 1 quarter.
  • Vermillion Wealth Management's Roivant Sciences position peaked at $1.63K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.